Current Psychopharmacology
Volume 10, 3 Issues, 2021
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
Aims & Scope
Current Psychopharmacology publishes peer-reviewed expert full-length/mini reviews, original research articles and single topic guest edited issues on all aspects of pre-clinical and clinical research in psychopharmacology. The journal aims to be the leading forum for expert review articles in the field. The journal also accepts high-level original research articles on outstanding topics of preclinical and clinical psychopharmacology.
Current Psychopharmacology
,Volume 10
-Number 1
Preface Open Access
Special Issue: College Age Substance and Mental Health Challenges and Opportunities in 2021
, 10(1): 1 - 2Mark S. Gold and Kenneth Blum
DOI: 10.2174/221155601001210125123949
Special Issue: College Age Substance and Mental Health Challenges and Opportunities in 2021
Biography Open Access
Meet Our Editor-in-Chief
Editorial Open Access
Evaluation and Treatment of Mental Health Disorders in College Students
, 10(1): 4Jessica A. Gold and Mark S. Gold
DOI: 10.2174/221155601001210125124654
Evaluation and Treatment of Mental Health Disorders in College Students
Review Article
Combatting the Epidemic of E-cigarette Use and Vaping among Students and Transitional-age Youth
, 10(1): 5 - 16Lisa Domenico, Christina E. DeRemer, Kathy L. Nichols, Christopher Campbell, Jacquelyn R. Moreau, Gail S. Childs and Lisa J. Merlo*
DOI: 10.2174/2211556009999200613224100
Combatting the Epidemic of E-cigarette Use and Vaping among Students and Transitional-age Youth
Review Article Open Access
The Impact and Sequelae of Sexual Victimization of Graduate and Professional Students
, 10(1): 17 - 23Philip Hemphill* and Margaret Reynolds
DOI: 10.2174/2211556009999200730115827
The Impact and Sequelae of Sexual Victimization of Graduate and Professional Students
Review Article
Assessing Collegiate Recovery Programs and the Challenges of Campus Binge Drinking
, 10(1): 24 - 33Andrew Downing* and Jessica Hulsey
DOI: 10.2174/2211556009999200817134231
Assessing Collegiate Recovery Programs and the Challenges of Campus Binge Drinking
Review Article
ADHD in College Students - a Guide for Clinicians and Administrators
, 10(1): 34 - 46Aaron Winkler*, Bettina Bohle-Frankel, Leigh White, Gordon Strauss and Diane Gottlieb
DOI: 10.2174/2211556009999200616132427
ADHD in College Students - a Guide for Clinicians and Administrators
Review Article
Early Psychosis: Diagnosis and Treatment
, 10(1): 47 - 56Nataly S. Beck, Melanie L. Lean, Kate V. Hardy and Jacob S. Ballon*
DOI: 10.2174/2211556009999200723123322
Early Psychosis: Diagnosis and Treatment
Articles Ahead of Print
Endorphinergic Enhancement Attenuation of Post-Traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Kenneth Blum*, Edward J. Modestino, David Baron, Raymond Brewer, P. K. Thanos, Igor Elman, Rajendra D. Badgaiyan, B. William Downs, Debasis Bagchi, Thomas McLaughlin, Abdalla Bowirrat, A. Kenison Roy and Mark S. Gold
DOI: 10.2174/2211556009999210104221215
View Abstract
Benzodiazepines, Amphetamines, Testosterone, and Sildenafil as New Candidate Drugs for Sexual Interest, Desire and/or Arousal Disorder
Richard Joseph Wix* and Ezequiel Uribe
DOI: 10.2174/2211556010666210301144022
View Abstract
The Rapidly Changing Composition of the Global Street Drug Supply and Its Effects on High-Risk Groups for COVID-19
Thom Browne*, Mark S. Gold and David M. Martin
DOI: 10.2174/2211556010666210125124645
View Abstract
Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise
Bernard W. Downs*, Steve Kushner, Manashi Bagchi, Kenneth Blum, Rajendra D. Badgaiyan and Debasis Bagchi
DOI: 10.2174/2211556010666210122145526
View Abstract
The Role of Folate-Supplementation in Depression: A Narrative Review
Falade Joshua*, Onaolapo Adejoke Yetunde and Onaolapo Olakunle James
DOI: 10.2174/2211556009666201207233954
View Abstract
Current Neuropharmacological Interventions in Autism: Potential Drug Targets from Pre-clinical and Clinical Findings
Ramit Sharma, Aarti Tiwari, Saloni Rahi and Sidharth Mehan*
DOI: 10.2174/1389203721999200820165117
View Abstract
A Comparative Study between Lithium and Extended-release Carbamazepine in Acute Mania: A Double-blind Clinical Trial
Saeed Shoja Shafti* and Hamid Kaviani
DOI: 10.2174/2211556009999200616130803
View Abstract
Abstracts Ahead of Print
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development
Kenneth Blum*, Abdalla Bowirrat , Marjorie C. Gondre Lewis, Thomas A. Simpatico , Mauro Ceccanti, Bruce Steinberg, Edward J Modestino, Panayotis K Thanos , David Baron, Thomas McLaughlin , Raymond Brewer, Rajendra D. Badgaiyan, Jessica Valdez Ponce, Lisa Lott and Mark S Gold
DOI: 10.2174/2211556010666210215155509
View Abstract
Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeostatic Signaling
Kenneth Blum*, Thomas McLaughlin, Edward J. Modestino, David Baron, Abdalla Bowirrat, Raymond Brewer , Bruce Steinberg, A. Kenison Roy, Marcello Febo, Rajendra D. Badgaiyan and Marks S. Gold
DOI: 10.2174/2211556010666210215153513
View Abstract
Dopaminylation in Psychostimulant use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression
Kenneth Blum*, Mark S Gold, Jean L. Cadet, David Baron, Abdalla Bowirrat, Panayotis K. Thanos, Raymond Brewer, Rajendra D. Badgaiyan and Marjorie C. Gondré–Lewis
DOI: 10.2174/2211556009666210108112737
View Abstract
Published Contents
Editor's Choice
Early Psychosis: Diagnosis and Treatment
, 2021; 10(1): 47 - 56Nataly S. Beck, Melanie L. Lean, Kate V. Hardy and Jacob S. Ballon*
DOI: 10.2174/2211556009999200723123322
Improvement of Negative Symptoms in Schizophrenia: A Double-blind Clinical Trial by Escitalopram in Male Patients
, 2020; 9(3): 211 - 217Saeed S. Shafti*
DOI: 10.2174/2211556009999200513074605
Role of Neurochemicals in Schizophrenia
, 2020; 9(2): 144 - 161Sher Singh, Deepa Khanna* and Sanjeev Kalra
DOI: 10.2174/2211556009666200401150756
In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing
, 2020; 9(1): 7 - 21Kenneth Blum*, David Baron, Lisa Lott, Jessica V. Ponce, David Siwicki, Brent Boyett, Bruce Steinberg, Edward J. Modestino, Lyle Fried, Mary Hauser, Thomas Simpatico, Bill W. Downs, Thomas McLaughlin, Raju Hajela and Rajendra D. Badgaiyan
DOI: 10.2174/2211556008666191111103152
Rapid Anti-Depressant Relief by Ketamine: Exploring A Complex Mechanism of Action
, 2019; 8(2): 99 - 112Kenneth Blum*, Todd C. Pappas, Bryan Clifton, David Baron, Margaret A. Madigan, Lisa Lott, Mark Moran, Cannon Clifton, Scott Worrich, Ervey Clarke, Brent Boyett, Abdalla Bowirrat and Mark S. Gold
DOI: 10.2174/2211556008666190827150018
Psychopharmacology for Patients with Parkinson’s Disease and Deep Brain Stimulation: Lessons Learned in an Academic Center
, 2019; 8(1): 41 - 54Andreea L. Seritan*, Peter Ureste, Tammy Duong and Jill L. Ostrem
DOI: 10.2174/2211556007666180328142953
Mechanistic Description of Natural Herbs in the Treatment of Dementia: A Systematic Review
, 2018; 7(2): 149 - 164Bapi Gorain*, Hira Choudhury, Manisha Pandey, Hasbi Laili Bt Mohd Zaki, Nuurul Izzati Bt Bakar, Nur Hanis Bt Hamdhan, Nor Aniza Bt Musa, Nurul Fadhilah Bt Mustafa, Jaya Sree Sangkari, Nur Ain Athirah Bt Azmi, Lui Park Yeang and Prashant Kesharwani
DOI: 10.2174/2211556007666180420124544
Management of Adverse Effects from Atypical Antipsychotics
, 2018; 7(1): 23 - 35Ahsan Nazeer* and Joseph L. Calles
DOI: 10.2174/2211556007666180220162945
Psychiatric Polypharmacy, Etiology and Potential Consequences
, 2017; 6(1): 12 - 26Sonali Sarkar*
DOI: 10.2174/2211556005666160916124719
Open Access Articles
The Impact and Sequelae of Sexual Victimization of Graduate and Professional Students
, 2021; 10(1): 17 - 23Philip Hemphill* and Margaret Reynolds
The Rapidly Changing Composition of the Global Street Drug Supply and Its Effects on High-Risk Groups for COVID-19
, 2021; 10: 1 - 17 (E-Pub Ahead of Print)Thom Browne*, Mark S. Gold and David M. Martin
Method Validation for the Determination of Carbamazepine in Spiked-saliva Using HPLC-UV for Therapeutic Drug Monitoring Application
, 2020; 9(3): 234 - 241Ari Wibowo, Vitarani D.A. Ningrum* and Rahma N. Ilhamy
Role of Neurochemicals in Schizophrenia
, 2020; 9(2): 144 - 161Sher Singh, Deepa Khanna* and Sanjeev Kalra
In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing
, 2020; 9(1): 7 - 21Kenneth Blum*, David Baron, Lisa Lott, Jessica V. Ponce, David Siwicki, Brent Boyett, Bruce Steinberg, Edward J. Modestino, Lyle Fried, Mary Hauser, Thomas Simpatico, Bill W. Downs, Thomas McLaughlin, Raju Hajela and Rajendra D. Badgaiyan
Oxidative Stress Targeting Amyloid Beta Accumulation and Clearance in Alzheimer’s Disease: Insight into Pathological Mechanisms and Therapeutic Strategies
, 2020; 9(1): 22 - 42Sunpreet Kaur, Puneet Kumar and Shamsher Singh*
Sudden Death Associated with Complex Treatment of Acute Mania: Case Report and Toxicological Findings
, 2019; 8(3): 238 - 243Martina Curto*, Luana Lionetto, Maria Chiara David, Aniello Maiese, Stefano Ferracuti, Maurizio Simmaco and Ross J. Baldessarini
Evaluation of Antipsychotic Activity of Ethanolic Extract of Dhatryadi Ghrita on Wistar Rats
, 2019; 8(3): 213 - 237Rashmi S. Pal* and Amrita Mishra
Neuroleptic Malignant Syndrome: A Pilot Study on Psychiatric Inpatients in Iran
, 2019; 8(3): 207 - 212Saeed S. Shafti*, Alireza Memarie, Masomeh Rezaie and Masomeh Hamidi
Psychotropic Medication Use among Traumatized Individuals with and without Psychiatric Histories
, 2019; 8(3): 194 - 206Alan R. King*, Sara K. Kuhn, Stephanie Brezinski, Michael Jowkar and Kourtney Smith
An Insight on the Association of Psychological Studies, Cognitive Sciences and Meditation in Treating Depression
, 2019; 8(3): 177 - 193Rashmi S. Pal*, Nikita Saraswat, Pranay Wal, Ankita Wal, Yogendra Pal and Tamsheel F. Roohi
GABRB2 in Neuropsychiatric Disorders: Genetic Associations and Functional Evidences
, 2019; 8(3): 166 - 176Shui Y. Tsang, Ata Ullah and Hong Xue*
Rapid Anti-Depressant Relief by Ketamine: Exploring A Complex Mechanism of Action
, 2019; 8(2): 99 - 112Kenneth Blum*, Todd C. Pappas, Bryan Clifton, David Baron, Margaret A. Madigan, Lisa Lott, Mark Moran, Cannon Clifton, Scott Worrich, Ervey Clarke, Brent Boyett, Abdalla Bowirrat and Mark S. Gold
Neurosteroids and Affective Disorders in Women
, 2019; 8(2): 89 - 98Rodrigo Guiza-Zayas*, Mónica Flores-Ramos, Norma Bernal-Santamaría, María Fernanda Del-Pino Mijares and Marián Serna-García
Sertraline Associated with REM Sleep Behavior Disorder: A Case Report
, 2019; 8(2): 159 - 162Seyed Mostafa Mansouripour * and Dharmendra Kumar
Most Cited Articles
Pharmacological Manipulation of Shoaling Behavior in Zebrafish
, 2016; 5(2): 180-193.Soaleha Shams and Robert T. Gerlai
DOI: 10.2174/2211556005666160607094906
Odyssey of ‘Negative Symptoms’ of Schizophrenia: Rehabilitation vs Stigmatization
, 2015; 4(1): 40-51.Saeed Shoja Shafti
DOI: 10.2174/2211556004666150918193742
The Novel Tank Test: Handling Stress and the Context Specific Psychopharmacology of Anxiety
, 2016; 5(2): 169-179.Steven Tran and Robert T. Gerlai
DOI: 10.2174/2211556005666160519144414
Relevance of Test- and Subject-Related Factors on Inhibitory Avoidance (Performance) of Zebrafish for Psychopharmacology Studies
, 2016; 5(2): 152-168.Remy Manuel, Marnix Gorissen and Ruud van den Bos
DOI: 10.2174/2211556005666160526111427
A Review of Monoaminergic Neuropsychopharmacology in Zebrafish, 6 Years Later: Towards Paradoxes and their Solution
, 2016; 5(2): 96-138.Caio Maximino, Bruna P. Costa and Monica G. Lima
DOI: 10.2174/2211556005666160527105104
Zebrafish as an Animal Model to Study Epileptic Seizures and Epileptic Syndromes
, 2016; 5(2): 194-210.Ben H.M. Mussulini, Suelen Baggio, Luana Moro, Renato D. Dias, Maria E. Calcagnotto, Eduardo P. Rico and Diogo L. de Oliveira
DOI: 10.2174/2211556005666160615090734
Zebrafish Models to Study Fear and Anxiety
, 2016; 5(2): 139-151.Adam D. Collier and David J. Echevarria
DOI: 10.2174/2211556005666160608124610
Most Accessed Articles
ADHD in College Students - a Guide for Clinicians and Administrators
, 2021; 10(1): 34-46.Aaron Winkler*, Bettina Bohle-Frankel, Leigh White, Gordon Strauss and Diane Gottlieb
DOI: 10.2174/2211556009999200616132427
Combatting the Epidemic of E-cigarette Use and Vaping among Students and Transitional-age Youth
, 2021; 10(1): 5-16.Lisa Domenico, Christina E. DeRemer, Kathy L. Nichols, Christopher Campbell, Jacquelyn R. Moreau, Gail S. Childs and Lisa J. Merlo*
DOI: 10.2174/2211556009999200613224100
Overview on Phyto-based Treatment for Anxiety
, 2020; 9(3): 185-210.Jyoti Alambayan and Vandana Garg*
DOI: 10.2174/2211556009999200723122833
The Impact and Sequelae of Sexual Victimization of Graduate and Professional Students
, 2021; 10(1): 17-23.Philip Hemphill* and Margaret Reynolds
DOI: 10.2174/2211556009999200730115827
Method Validation for the Determination of Carbamazepine in Spiked-saliva Using HPLC-UV for Therapeutic Drug Monitoring Application
, 2020; 9(3): 234-241.Ari Wibowo, Vitarani D.A. Ningrum* and Rahma N. Ilhamy
DOI: 10.2174/2211556009999200727191226
Assessing Collegiate Recovery Programs and the Challenges of Campus Binge Drinking
, 2021; 10(1): 24-33.Andrew Downing* and Jessica Hulsey
DOI: 10.2174/2211556009999200817134231
Anxiety Disorders’ Effect on College and University Students’ Mental Health: A Common and Growing Concern
, 2020; 9(2): 82-90.Matthew J. Pesko*
DOI: 10.2174/2211556009999200408105509
Early Psychosis: Diagnosis and Treatment
, 2021; 10(1): 47-56.Nataly S. Beck, Melanie L. Lean, Kate V. Hardy and Jacob S. Ballon*
DOI: 10.2174/2211556009999200723123322
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-induced Hyperalgesia
, 2020; 9(3): 164-184.Raymond Brewer, Kenneth Blum*, Abdalla Bowirrat, Edward J. Modestino, David Baron, Rajendra D. Badgaiyan, Mark Moran, Brent Boyett and Mark S. Gold
DOI: 10.2174/2211556009999200628093231
Addressing Depression and Suicidality in the College Population
, 2021; 10(1): 62-72.Amy W. Alexander*, Marcia Morris and Mehak Chopra
DOI: 10.2174/2211556009999201210121049
Medication-precipitated Seizure in Psychiatric Patients: Typical vs. Atypical Antipsychotics
, 2020; 9(3): 228-233.Saeed S. Shafti*
DOI: 10.2174/2211556009999200606221247
Oxidative Stress Targeting Amyloid Beta Accumulation and Clearance in Alzheimer’s Disease: Insight into Pathological Mechanisms and Therapeutic Strategies
, 2020; 9(1): 22-42.Sunpreet Kaur, Puneet Kumar and Shamsher Singh*
DOI: 10.2174/2211556009666191231155927
The Plastic and Functional Changes in Hippocampal Neurons During Pregnancy, Delivery and Postpartum are Reversed by Offspring Deprivation
, 2021; 10(1): 73-83.Maria C. Mostallino*, Pietro P. Secci, Elena Paci, Maria L. Mura, Elisabetta Maciocco, Enrico Sanna and Giovanni Biggio
DOI: 10.2174/2211556009999200819102313
A Study of Metabolic Syndrome in Patients on Risperidone
, 2020; 9(3): 218-227.Ajay Thangraj, Nimesh G. Desai and Vijender Singh*
DOI: 10.2174/2211556009666200316143613
Transitioning from Child and Adolescent to Adult Psychiatric Care: Improving Outcomes after University Matriculation
, 2021; 10(1): 57-61.Giuseppe D’Amelio* and Jessica A. Gold
DOI: 10.2174/2211556009999200616131458
Editor-in-Chief
Kenneth Blum
Western University of Health Sciences
Pomona, CA
(USA)
Biography
Western University of Health Sciences
Pomona, CA
Biography
Biography of Kenneth Blum
Dr. Blum serves as Chairman of Geneus Sciences LLC., His concept of Reward Deficiency Syndrome is
being embraced by world leaders in science and is part of the DSM –V, ASAM, Sage Encyclopedia of abnormal and clinical psychology 2017. Dr, Blum is credited with the DRD2 gene discovery and addictive diseases. He
serves as Editor-in-Chief in Journal of Reward Deficiency Syndrome (he coined) and Addiction Sciences
and Co-EIC of Journal of Neuroimaging in Psychiatry and Neurology (USG). He is currently serving on
fourteen other prestigious journal’s Editorial Boards. He has published over 450 articles, 16 books,
numerous patents and received many awards (Life-Time Achievements) for his seminal discoveries. He is
the founding President of United Scientific Group (USG).
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Psychopharmacology was launched in 2012. Dr. Kenneth Blum serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net